Dec 2007
2008 Research
2007
Research
2006
Research
2005
Research
2004-2001 Research Archives
Cancer Surveillance Futile in Advanced
Cirrhosis
Non-invasive FibroTest and FibroScan Predict Liver
Cirrhosis Better than Earlier Stages of Fibrosis in Hepatitis C Patients
Eltrombopag for Thrombocytopenia in Patients
with Cirrhosis Associated with Hepatitis C
-
Treating Patients with Cirrhosis
Non-Invasive Tests for Cirrhosis May Help to Avoid
Liver Biopsy
Nexavar First FDA-Approved Drug Therapy for Liver
Cancer
HCV Treatment Aided by New Platelet-Boosting Drug
Nov 2007
Clinical Relevance of Rapid Virological Response (RVR)
in Decompensated HCV-Related Cirrhosis Treated With Peginterferon and
Ribavirin
MAINTENANCE THERAPY FOUND INEFFECTIVE HALT-C STUDY
Hepatitis C and Decompensated Cirrhosis Improve With
Combination Therapy, Individualized Approach: Presented at AASLD
What is the best non invasive method for early
prediction of cirrhosis in chronic hepatitis C? Prospective comparison
between Fibroscan and serum markers (Lok index, APRI, AST/ALT ratio,
platelet count and Fibrotest) -
Danazol Increases Platelet Counts in Thrombocytopenia
Patients with Chronic Hepatitis C or Cirrhosis
-
Positive Impact of Antiviral Therapy on the Long Term
Outcome of Chronic Hepatitis C Patients with Cirrhosis
Consensus Interferon in Hepatitis C Is an Option for
Those Non-Responsive to Peginterferon/Ribavrin: Presented at AASLD
Long-term prognosis of elderly patients with hepatitis
C virus-related chronic liver disease --- A cohort study of 2,379 Japanese
patients
Hepatocellular carcinoma in long-term sustained
virologic responders to antiviral treatment for chronic hepatitis C
Treatment of Hepatitis C Patients with Child A and B
cirrhosis with Consensus Interferon and Ribavirin in a Low Ascending Dosing
Regimen Leads to Significant Viral Elimination Rates
Bone mineral density and metabolism in non-cirrhotic
patients with chronic hepatitis C before and after antiviral therapy with
pegylated interferon α and ribavirin: a prospective controlled study
Clinical Relevance of Rapid Virological Response (RVR)
in Decompensated HCV-Related Cirrhosis Treated with PEG-Interferon and
Ribavirin
Long-Term, Low-Dose Treatment With Pegylated
Interferon alfa-2b Leads to a Significant Reduction in Fibrosis and
Inflammatory Scores in Chronic Hepatitis C Nonresponder Patients With
Fibrosis or Cirrhosis
HCV Advocate’s AASLD NOV 2007 Conference
coverage
Nov 2007
Disease Progression:
Various
factors that influence HCV disease progression including steatosis,
obesity, insulin resistance, diabetes, race/ethnicity, and general
studies on disease progression.
·
General
o
1330. Effects of chronic HCV infection on health-related quality of life
and fatigue: the role of liver fibrosis progression
(updated
November 6,
2007)
o
1336. Tracking the Course of Hepatitis C with Paired Biopsies - A
Critical Analysis
(updated
November 6,
2007)
o
1337. Long-term Morbidity and Mortality of HCV Infection: A 25 years
Follow-up
o
1340. Histological Outcomes After 30 Years In Untreated Irish Women With
Chronic HCV Genotype 1b, Do Genetic Factors Influence?
(updated
November 6,
2007)
o
1341. Higher Caffeine Consumption is associated with Milder Fibrosis in
patients with Chronic Liver Diseases
o
1347. Obesity is an Independent predictor of fibrosis progression in
patients with chronic Hepatitis C Virus (HCV) using paired liver biopsy
specimens
(updated
November 6,
2007)
o
1360. Cause of Death in Patients with Hepatitis C (HCV)-Mixed
Cryoglobulinemia (MC) Vasculitis
o
1366. Host rather than viral factors reduce health-related quality of
life in hepatitis C virus infection
·
Hepatocellular Carcinoma
o
133. Chronic hepatitis C virus infection and risk of hepatocellular
carcinoma: a community-based prospective study on 19,565 residents in
Taiwan
·
Metabolic
disorders
o
533. High Prevalence of Glomerulonephritis in Patients with End-stage
HCV-induced Cirrhosis
·
Race
o
354. The Role of Steatosis and Diabetes as a Predictor of Treatment
Response to Interferon Based Therapies in Latino Americans with Chronic
Hepatitis C
·
Steatosis
o
301. The Impact Of Steatosis And Steatohepatitis On The Response To
Treatment In Patients With Chronic Hepatitis C Infection
Oct 2007
Cirrhosis in the Medical Intensive Care Unit - 1 of 4
Cirrhosis in the Medical Intensive Care Unit -
Management of the Patient With Cirrhosis and Acute GI
Cirrhosis in the Medical Intensive Care Unit -
Management of the Patient With Cirrhosis and Altered
Cirrhosis in the Medical Intensive Care Unit -
Management of the Patient With Cirrhosis and Infection
Researching Cure For Liver Cirrhosis
Predictors of Mortality in Hepatic Encephalopathy in
Acute and Chronic Liver Disease: A Preliminary
Propranolol Better First-Line Prophylaxis Than
Ligation for Variceal Bleeding
Insulin Resistance and
Diabetes
Minimal Hepatic Encephalopathy Associated With
Increased Traffic Accidents
FDA Safety Changes: Copegus, Intron A
Noninvasive Tests For Cirrhosis May Help To Avoid
Liver Biopsy
Monitoring HIV Disease Progression in People with
Cirrhosis
Anti-Cancer Drug PI-88 Awarded Fast Track Status by
the Food and Drug Administration
Sept-Aug-July-June 2007
The Use of Transient Elastometry for Assessing Liver Fibrosis in Patients
with HIV and Hepatitis C Virus Coinfection: only detects cirrhosis
Prolonged Interferon Therapy May Prevent Progression
of Hepatitis C to Cancer
Symptoms of Liver Disease & Risk
Factors for Upper GI Bleeding
New Marker for Liver Cancer May Allow for Earlier
Detection
Driving With Minimal Hepatic Encephalopathy: Real
World Consequences?
Patients with Depression prior to Hepatitis C
Treatment Are Half as Likely to Achieve Sustained Virological Response
Muscular exercise can cause highly
pathological liver function tests in healthy
Coffee Consumption May Reduce the Risk of Liver Cancer
IAS: Atazanavir safe and effective in HCV-coinfected
patients with cirrhosis
Stanford researchers develop new genetic marker test
to predict likelyhood for progression to cirrhosis of hcv patients:
Mitochondrial Toxicity
Obesity 'No. 1 liver issue'
Liver tonics not sure guard against liver diseases
Atorvastatin (Lipitor) lowers portal pressure in cirrhotic rats by
inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide
synthase -
Natural History of Hepatitis C in Patients with Severe
Liver Fibrosis
Ursodeoxycholic Acid May Reduce Liver Inflammation in
Patients with Chronic Hepatitis C
Liver Enzyme Flares and Occult HBV Infection in
Patients with Untreated Chronic Hepatitis C
The Emotional Impact of Leaving Work
on Disability
New Data Suggest that Patients with Chronic Liver
Disease are at Increased Risk for Heart Disease
Association of Hepatitis C Seropositivity With
Increased Risk for Developing End-stage Renal
Disease.
New acute liver failure research from
University of Texas, Department of Internal Medicine outlined
Milk Thistle (Silymarin) Demonstrates
Anti-inflammatory and Anti-HCV Activity in a Laboratory Study
Body composition, muscle function, and energy expenditure in patients with
liver cirrhosis: a comprehensive study
Treatment with Pegasys Plus Ribavirin in Genotype 2/3
Chronic Hepatitis C Patients with Liver Cirrhosis
Transient Elastography as a Non-invasive Method for
Predicting Portal Hypertension in Patients with Hepatitis C-related
Cirrhosis
A Follow-up Week 12 Viral Count Is Useful in
Predicting SVR and Is 100% Accurate in Patients without Cirrhosis
Early Pegasys/RBV Therapy is Cost Effective, Improves
Survival & Reduces Risk for Cirrhosis -
Cost-effectiveness, Survival, and Prevention of
Cirrhosis with Early Treatment of Chronic Hepatitis C with Peginterferon
Alfa-2a (40KD) plus Ribavirin before Progression to Advanced Liver Disease
-
Reversibility of hepatic fibrosis and cirrhosis-is it all hype? Editorial
Glucose Intolerance Associated with Advancing Liver
Disease (Fibrosis)
Body composition, muscle function, and energy expenditure in patients with
liver cirrhosis: a comprehensive study
May 2007
Sustained virological response to interferon reduces
cirrhosis in chronic hepatitis C: a 1386-patient
study from Taiwan.
Response to PegIntron/ribavirin Leads to Stabilization
of Fibrosis in Liver Transplant Recipients
Treatment
of hepatitis C virus infection.
Does SVR after Treatment with Pegasys/ribavirin
Constitute a Cure for Chronic Hepatitis C?
April-March 2007
Schering's Experimental Oral HCV Protease Inhibitor
Boceprevir Appears Safe in Patients with Varying Degrees of Liver Impairment
-
Roche Driving PROGRESS in Treatment of Difficult-to-Cure Hepatitis C
Patients With New PEGASYS (R) (peginterferon alfa-2a (40KD)) and COPEGUS(R)
(ribavirin) Trial -
Interferon Gamma Does Not Reverse Fibrosis in
Hepatitis C Patients with Advanced Liver Disease
Sustained Response to Interferon Monotherapy Reduces
Rates of Liver Cancer and Death in Patients with HCV-related Cirrhosis
Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and
decompensated cirrhosis: A controlled study
-
Improving Quality Of Life For Patients With
Cirrhosis
Liver problems: Common problems and how to
avoid them
Health-related Quality of Life in Chronic Hepatitis C
Patients with Advanced Fibrosis
Impact of Reducing Peginterferon Alfa-2a and Ribavirin Dose During
Retreatment in Patients With Chronic Hepatitis C (HALT-C Study)
-
From Our Message boards
CIRRHOSIS
February
Impact of Cirrhosis on CD4 Cell Counts in HIV Negative
Individuals Has Implications for HIV-HCV and HIV-HBV Coinfected Patients
Rapamycin Reduces Fibrosis and Improves Liver Function
in Rats
December-January
Liver transplant: Treating end-stage liver disease
HCV Continues to Replicate in the Livers of Patients
with Sustained Response to Therapy
Treatment of Hepatitis C in Patients with Advanced
Fibrosis or Cirrhosis
Impact of Disease Severity on HCV Treatment Outcomes
in HALT-C Trial
Treatment Response in Cirrhotic Hepatitis C Patients
with Portal Hypertension
In the new area of noninvasive markers of
hepatocellular carcinoma
Pathogenesis of osteoporosis in liver cirrhosis
You Are Invited: Clinical Care Options for Hepatitis
Symposium 2007
2008 Research
2007
Research
2006
Research
2005
Research
2004-2001 Research Archives
|
